Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 1.195
+0.220 (22.56%)
Sep 21, 2026, 11:57 AM HKT
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 415.98 million as of September 18, 2026. Its market cap has decreased by -76.92% in one year.
Market Cap
415.98M
Enterprise Value
571.01M
Revenue
32.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
ChartMarket Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 415.98M, a decrease of -84.90%. That is a compound annual growth rate of -34.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 415.98M | -56.39% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 898.73M |
| JW (Cayman) Therapeutics Co. | 892.97M |
| Wuhan YZY Biopharma | 639.70M |
| Brii Biosciences | 638.80M |
| 3D Medicines | 607.42M |
| B&K Corporation | 470.63M |
| Cutia Therapeutics | 436.04M |
| Uni-Bio Science Group | 435.90M |